Scott A Rollins Net Worth & Insider Trades

Scott A Rollins - Sr. VP Drug Dev. & Proj. Man., Alexion Pharmaceuticals Inc

As of June 8, 2005

What is Scott A Rollins's Net Worth?

The current estimated net worth of Alexion Pharmaceuticals Inc's Sr. VP Drug Dev. & Proj. Man., Scott A Rollins, is estimated to be about $42.27K . Scott A Rollins owns about 3,100 units of Alexion Pharmaceuticals Inc common stock. In the last 2 years at Alexion Pharmaceuticals Inc, Scott A Rollins has sold an estimated value of $42.27K worth.

What is Scott A Rollins's Past Insider Trading?

Scott A Rollins's largest sale order was 1,900 units , worth over $42.27K on June 8, 2005. In total, Scott A Rollins has made about 2 transactions over 2 years of their time at Alexion Pharmaceuticals Inc. Scott A Rollins usually trades in June, with the busiest year in 2003 and 2005.

Scott A Rollins

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Scott A Rollins's' Mailing Address?

  • Mailing address is C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 CT

Alexion Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ludwig Hantson 2019 $1,250,000 - $15,243,634 - $2,430,000 $24,350 $18,947,984
Ludwig Hantson 2018 $1,200,000 - $12,385,168 - $2,880,000 $25,082 $16,490,250
Ludwig Hantson 2017 $900,000 - $9,618,758 $2,282,881 $2,275,000 $233,428 $15,310,067
Aradhana Sarin 2019 $651,764 - $3,380,763 - $813,011 $31,604 $4,877,142
Paul Clancy 2019 $927,000 - $3,863,694 - $1,051,218 $23,832 $5,865,744
Paul Clancy 2018 $900,000 - $3,302,761 - $1,260,000 $23,752 $5,486,513
Paul Clancy 2017 $415,385 $500,000 $8,799,954 $1,220,082 $473,620 $2,262 $11,411,303
Brian Goff 2019 $740,000 - $3,863,694 - $923,076 $20,240 $5,547,010
Brian Goff 2018 $695,250 - $3,096,323 - $973,350 $111,873 $4,876,796
Brian Goff 2017 $381,634 $100,000 $2,390,026 $732,899 $434,380 $58,787 $4,097,726
Anne-Marie Law 2019 $695,000 - $3,622,303 - $788,130 $33,528 $5,138,961
Anne-Marie Law 2018 $650,000 - $2,889,885 - $910,000 $846,604 $5,296,489
Anne-Marie Law 2017 $362,500 $200,000 $2,300,015 - $410,472 $68,710 $3,341,697
John Orloff 2019 $770,000 - $3,863,694 - $960,498 $32,550 $5,626,742
John Orloff 2018 $695,250 - $3,096,323 - $973,350 $98,679 $4,863,602
John Orloff 2017 $376,442 $200,000 $2,499,995 - $472,500 $80,351 $3,629,288
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm

What are Alexion Pharmaceuticals Inc's Past Insider Trades?

Alexion Pharmaceuticals Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director,  Stephen Squinto, EVP,  and Vikas Sinha, EVP & CFO .

ALEXION PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1